首页 | 本学科首页   官方微博 | 高级检索  
检索        

视网膜色素变性治疗最新进展
引用本文:陈娟,马晓晔.视网膜色素变性治疗最新进展[J].眼科新进展,2012,32(2):188-191.
作者姓名:陈娟  马晓晔
作者单位:1. 海军总医院医学整形科, 北京市,100037
2. 第二军医大学附属长征医院眼科, 上海市,200003
摘    要:视网膜色素变性(retinitis pigmentosa,RP)是视网膜感光细胞和色素上皮细胞变性导致的最常见遗传性致盲眼病,预后不佳,目前尚无有效的预防和治愈方法。近年来,随着基因治疗、视网膜移植等技术在动物实验中的广泛开展,给人类RP的治疗带来了新的希望。本文对RP的各种最新治疗进展进行综述。

关 键 词:视网膜色素变性  基因治疗  干细胞移植  视网膜移植

Research advances on treatment of retinitis pigmentosa
CHEN Juan , MA Xiao-Ye.Research advances on treatment of retinitis pigmentosa[J].Recent Advances in Ophthalmology,2012,32(2):188-191.
Authors:CHEN Juan  MA Xiao-Ye
Institution:the Department of Plastic Surgery,Navy General Hospital(CHEN Juan),Beijing 100037,China;Department of Ophthalmology,Changzheng Hospital,the Second Military Medical University(MA Xiao-Ye),Shanghai 200003,China
Abstract:Retinitis pigmentosa(RP) is one of the common inherited diseases caused by photoreceptor cells and retinal pigment epithelial cell degeneration.The prognosis is often poor.There is without effective method to cure at present.In recent years,new method has been extensively used for the treatment of human RP in animal experiments such as gene therapy,retinal transplantation technology and so on.This review focuses on advancement in treatment of RP.
Keywords:retinitis pigmentosa  gene therapy  stem cell transplantation  retinal transplantation
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号